BSE Award For “Best Return To Investors” at 5th Pharmaceutical Leadership Awards Intensifies

Aanjaneya Lifecare, Divis Laboratories, TTK Healthcare,Ajanta Pharma are in the race for the prestigious title as India votes to choose the company who has maximized their Returns on Investments.
By: Pharmaleaders
 
Sept. 12, 2012 - PRLog -- BSE Award For “Best Return To Investors” at 5th Annual Pharmaceutical Leadership Awards 2012 Intensifies

Aanjaneya Lifecare, Divis Laboratories, TTK Healthcare,Ajanta Pharma are in the race for the prestigious title as India votes to choose the company who has maximized their Returns on Investments.

Mumbai, September 11, 2012: Pharrmaleaders, Asia’s biggest title in healthcare communications is gearing up to choose the top Pharmaceutical & Biotech Companies for their dramatic & significant accomplishments in their respective field at the 5th Annual Pharmaceutical Leadership Awards 2012 in as many as 33 categories, the biggest & coveted title that India is anxiously looking at is the Category that has made investors & stakeholder happy in the stock market. Organized in association with, Pharmexcil, IBEF & Ministry of Industry & Commerce, Government of India, the coveted  & prestigious title BSE  Award for the Best Return to Investors 2012 will be presented by Shri K. Shankaranarayan, His Excellency, Governor of Maharashtra on Friday 21st September at Hotel Hilton Mumbai International Airport amidst the presence of the veterans & who’s who’s of the Asia’s top Healthcare Leaders, Pharma Academia, Ministers, Policy Makers, Social Entrepreneurs & Medical Practioners. More than top 200 professionals of the Industry are expected to attend the much awaited Leadership Event with the representation of Overseas Companies.

Speaking on the Award Nomination, Satya Brahma, Chairman of the Juries & Editor-In-Chief of Pharmaleaders said “Pharmaleaders has institutionalized Pharmaceutical Leadership Awards since 1999 to honour & recognize the successful companies & individuals who have made their mark & contributed vigorously to the growth of Indian Economy & foreign exchange. Although there are many successful Pharmaceutical Companies listed in BSE are doing well, however, the attempt by the juries to nominate the mid-sized companies such as Aanjaneya Lifecare, Divis Laboratories, TTK Healthcare,Ajanta Pharma are indeed judicious choices as all four companies are doing exceedingly well in the Healthcare Index. The Public, Investors & Companies who are choosing the Winner will truly be a fitting recognition”.  “This category has attracted tremendous attention in the stock market, Pharma Companies & in the general public as corporate ethics, Corporate Sustainability Model are the norms of the day & with so much of scrutiny by the regulators, BSE Award for the Best Return to the Investors will be a tight contest”.              

To quote Kiran Kabtta Somvanshi  of ET “ Of late there are many Midcaps in Healthcare doing exceedingly well. Consider this, the stocks of most leading pharma companies have hit a new high or a 52-week high since August. Stocks of companies like Cipla, Sun Pharma, Lupin, Wockhardt, Strides Arcolabs, Divi's Labs, Ipca Labs, Indoco Remedies Alembic Pharma and Shasun Pharma have hit a new high on the bourses. Likewise, stocks of Ranbaxy Labs, Glenmark Pharma, Dishman Pharma, Cadila Healthcare, Unichem Labs and Venus Remedies have hit a 52-week high. With macro economic conditions being difficult and most sectors not doing well, the market is chasing all growth-oriented companies in the defensive sectors of FMCG and now Pharma stocks, defensive sector, valuations, FMCGarma.Given the limited opportunity in the market, the Street has now turned to pharma stocks to capture growth and value. Most pharma companies with decent growth performance has witnessed a rally in its stock. 32% of the total 148 listed pharma stocks have flared up to new or 52-week highs in the last one month.The Indian pharma market is growing at 16-18%. Most Indian companies earn substantial revenues from outside by selling low-cost generic drugs in regulated markets. The industry is growing at an average rate of 20-22%. Many Indian companies like Sun Pharma, Dr Reddy's Labs and Glenmark are among the fastest growing generic companies in the world. With the market now chasing the drug company stocks, the valuations of these companies is likely to become expensive. The ET Pharma Index is trading at a price to earnings multiple of 33 very close to the 34.6 P/E of ET FMCG Index.

Dr Kannan Vishwanath led Aanjaneya Lifecare which specializes in niche segments has a strong presence in API and formulation business and has bulk drug manufacturing facility at Mahad and a finished dosage forms unit near Pune. It is one of the largest contract manufacturers of codeine-based cough syrups in India and exclusively makes Codorex brand of Zydus Cadilla and Codilite tablets among others. It recently raised around Rs 117 crore through an initial public offering (IPO). It acquired recentlyApex Drugs and Intermediates (ADI), a Hyderabad-based integrated active pharmaceutical ingredient (API) and intermediate company, for Rs.250 crore, including debt of Rs.185 crore and equity dilution of Rs.65 crore.

Divi’s Laboratories has earned a consolidated total income of Rs.722 crores for the 4th Quarter of the year 2011-12 as against a total income of Rs.480 crores during the corresponding quarter last year, reflecting a growth of 50%. Established in the year 1990, with Research & Development as its prime fundamental, Divis  Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Purushottam B. Agrawal Led Ajanta Pharma is a specialty pharmaceutical company engaged in the development, manufacture and commercialization of pharmaceutical products. We employ over 3,500 people worldwide and our products are sold in over 30 countries. Ajanta operates with 5 state-of-the art manufacturing facilities that produce high quality pharmaceutical products. We focus on commercializing unique generic products and pioneering synergistic combination products in the therapeutic areas of anti- malarial, cardiology, dermatology, gastroenterology, musculoskeletal, ophthalmology and respiratory is also doing quite well.
Chennai based TTK Healthcare manufactures calcium supplements, haematinics, cervical dilators, thrombolytic agents, rejuvenators, multimineral supplements, liver correctives and pain management products.Besides being the first Pharmaceutical Company in India to be awarded the ISO certification by BIS, TTK Healthcare was also the first to launch technology-driven life-saving products like Urokinase and Dopamine. The Company has also developed medicines like Lactare based on Ayurveda - the ancient traditional system of medicine.

About 5th Annual Pharmaceutical Leadership Awards 2012.
Pharmaceutical Business Leadership Award Nominations 2012 has been carefully selected in 33 categories with several new entrants making it to the top category & big league as a result of their rising market presence.
•   Financial management,  
•   Decision making roles and business impact. •Business ethics.
•   Managing rapid growth.
•   Innovation.
•   Adapting to change.
•   Strategic partnerships.
•   Leadership roles.
•   Marketing strategies.
•   Corporate philanthropy to society.


The Award for the Best Return to Investors will be presented once the results for the Nomination process will end & the final vote count on 21st September, Friday 2012 in Mumbai .   The Winner will be presented an Award Trophy & a certificate of Excellence.
End
Source:Pharmaleaders
Email:***@pharmaleaders.co.in
Zip:564321
Tags:Pharmaleaders, Pharmanewsprwire, Pharmaceutical Leadership Summit, Aanjaneya
Industry:Health, Pharma
Location:Bangalore - Karnataka - India
Subject:Products
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
India Leadership Conclave PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share